Korean Journal of Chemical Engineering, Vol.27, No.4, 1042-1048, 2010
Cellular engineering for the high-level production of recombinant proteins in mammalian cell systems
The market for protein-drugs has steadily increased due their increased use as alternatives to traditional small molecule drugs. While some therapeutic proteins have been produced in microbial systems, mammalian cell systems such as Chinese hamster ovary (CHO) cells are widely used as the host cell system. To increase the efficiency of producing therapeutic proteins, many researchers have attempted to solve the critical problems that occur in mammalian cell systems. As a result, several serum-free media and advanced culture methods have been developed, and protein productivity has increased considerably through the development of efficient selection methods. However, the prevalence of apoptosis during mammalian cell culture still remains a significant problem. Based on the understanding of apoptotic mechanisms and related proteins, anti-apoptotic engineering has steadily progressed. In this study, we review the strategies that have been developed for high-level production of recombinant proteins in the CHO cell system via a selection of clones, target-gene amplification, optimization of culture systems and an inhibition of apoptosis through genetic modification.
[References]
Walsh G, Nat. Biotechnol. , 21 , 865, 2003
Wurm FM, Nat. Biotechnol. , 22 , 1393, 2004
Robinson DK, Memmert KW, Biotechnol. Bioeng. , 38 , 972, 1991
Kwaks THJ, Otte AP, Trends Biotechnol. , 24 , 137, 2006
Wilson TJ, Kola I, Methods Mol. Biol. , 158 , 83, 2001
Urlaub G, Chasin LA, Proc. Natl. Acad. Sci. USA. , 77 , 4216, 1980
Urlaub G, Kas E, Carothers AM, Chasin LA, Cell. , 33 , 405, 1983
Pallavicini MG, DeTeresa PS, Rosette C, Gray JW, Wurm FM, Mol. Cell. Biol. , 10 , 401, 1990
Gandor C, Leist C, Fiechter A, Asselbergs FAM, Febs Lett. , 377 , 290, 1995
Wirth M, Bode J, Zettlmeissl G, Hauser H, Gene. , 73 , 419, 1988
Browne SM, Al-Rubeai M, Trends Biotechnol. , 25 , 425, 2007
Sinacore MS, Drapeau D, Adamson SR, Mol. Biotechnol. , 15 , 249, 2000
De Jesus MJ, Girard P, Bourgeois M, Baumgartner G, Jacko B, Amstutz H, Wurm FM, Biochem. Eng. J. , 17 , 217, 2004
Walker NI, Harmon BV, Gobe GC, Kerr JF, Methods Achiev. Exp. Pathol. , 13 , 18, 1988
Wyllie AH, Morris RG, Smith AL, Dunlop D, J. Pathol. , 142 , 66, 1984
Susin SA, Zamzami N, Kroemer G, Biochim. Biophys. Acta. , 1366 , 151, 1998
Liu X, Kim CN, Yang J, Jemmerson R, Wang X, Cell. , 86 , 147, 1996
Ashkenazi A, Nat. Rev. Cancer. , 2 , 420, 2002
Oyadomari S, Araki E, Mori M, Apoptosis. , 7 , 335, 2002
Adam JM, Cory S, Curr. Opin. Cell Biol. , 14 , 715, 2002
Subramanian T, Chinnadurai G, J. Cell. Biochem. , 89 , 1102, 2003
Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM, Nature , 379 (6565), 554, 1996
Mastrangelo AJ, Betenbaugh MJ, Trends Biotechnol. , 16 , 88, 1998
Arden N, Betenbaugh MJ, Trends Biotechnol. , 22 , 174, 2004
Sanfeliu A, Stephanopoulos G, Biotechnol. Bioeng. , 64 (1), 46, 1999
Zanghi JA, Renner WA, Bailey JE, Fussenegger M, Biotechnol. Prog. , 16 (3), 319, 2000
Balcarcel RR, Stephanopoulos G, Biotechnol. Bioeng. , 76 (1), 1, 2001
Tinto A, Gabernet C, Vives J, Prats E, Cairo JJ, Cornudella L, Godia F, J. Biotechnol. , 95 , 205, 2002
Sauerwald TM, Oyler GA, Betenbaugh MJ, Biotechnol. Bioeng. , 81 (3), 329, 2003
McKenna SL, Cotter TG, Biotechnol. Bioeng. , 67 (2), 165, 2000
Vives J, Juanola S, Cairo JJ, Godia F, Metab. Eng. , 5 , 124, 2003
Vives J, Juanola S, Cairo JJ, Prats E, Cornudella L, Godia F, Biotechnol. Prog. , 19 (1), 84, 2003
Mastrangelo AJ, Hardwick JM, Bex F, Betenbaugh MJ, Biotechnol. Bioeng. , 67 (5), 544, 2000
Sung YH, Lee GM, Biotechnol. Prog. , 21 (1), 50, 2005
Figueroa B, Sauerwald TM, Oyler GA, Hardwick JM, Betenbaugh MJ, Metab. Eng. , 5 , 230, 2003
Lasunskaia EB, Fridlianskaia II, Darieva ZA, da Silva MSR, Kanashiro MM, Margulis BA, Biotechnol. Bioeng. , 81 (4), 496, 2003
Hwang SO, Lee GM, J. Biotechnol. , 139 , 89, 2009
Kim NS, Lee GM, Biotechnol. Bioeng. , 78 (2), 217, 2002
Sung YH, Lee JS, Park SH, Koo J, Lee GM, Metab. Eng. , 9 , 452, 2007
Rhee WJ, Kim EJ, Park TH, Biotechnol. Prog. , 15 (6), 1028, 1999
Rhee WJ, Park TH, Biochem. Biophys. Res. Commun. , 271 (1), 186, 2000
Rhee WJ, Kim EJ, Park TH, Biochem. Biophys. Res. Commun. , 295 (4), 779, 2002
Choi SS, Rhee WJ, Park TH, Biotechnol. Prog. , 18 (4), 874, 2002
Kim EJ, Rhee WJ, Park TH, Biochem. Biophys. Res. Commun. , 285 (2), 224, 2001
Kim EJ, Park HJ, Park TH, Biochem. Biophys. Res. Commun. , 308 (3), 523, 2003
Park HJ, Kim EJ, Koo TY, Park TH, Enzyme Microb. Technol. , 33 (4), 466, 2003
Kim EJ, Rhee WJ, Park TH, Biotechnol. Prog. , 20 (1), 324, 2004
Rhee WJ, Lee EH, Park TH, Biotechnol. Bioprocess Eng. , 14 , 645, 2009
Kim EJ, Park TH, Biotechnol. Bioprocess Eng. , 8 , 76, 2003
Rhee WJ, Lee EH, Park JH, Lee JE, Park TH, Biotechnol. Prog. , 23 (6), 1441, 2007
Choi SS, Rhee WJ, Park TH, Biotechnol. Bioeng. , 91 (7), 793, 2005
Choi SS, Rhee WJ, Kim EJ, Park TH, Biotechnol. Bioeng. , 95 (3), 459, 2006
Park JG, Choi SS, Park TH, Process Biochem. , 42 , 8, 2007
Koo TY, Park JH, Park HH, Park TH, Process Biochem. , 44 , 146, 2009
Wang Z, Park JH, Park HH, Tan W, Park TH, Process Biochem. , in press, doi:10.1016/j.procbio.2010.03.029, 2010
이전 논문 다음 논문
Result Search